Clinical Trial Design in the Age of Precision Medicine and Health
Fee may apply
Traditional designs for Phase I, II, and III clinical trials for medical product approval and Phase IV postmarketing studies for safety evaluation cost too much and take too much time in the era of precision medicine and precision health. This course introduces innovative designs that have been developed for aordable clinical trials, which can be completed within reasonable time constraints and which have been encouraged by regulatory agencies..
What you will learn
- Adaptive designs with valid frequentist inference
- Enrichment designs with adaptive patient subgroup selection, with examples from cancer and stroke therapies
- Master protocols for umbrella, platform and basket trials, with concrete examples
- Real-world evidence and patient-focused medical product development
- STATS200 or equivalent
- Working knowledge of clinical trials
|Dates:||March 30 - June 3, 2020|
Provides Stanford University credit that may later be applied towards a graduate degree or certificate. Includes access to online course materials and videos for the duration of the academic quarter. Starting Autumn 2016 there is a $100 fee per course for courses dropped before the drop deadline. Click here for more information about our Registration Policies.
*Note: All amounts shown are in USD
NotesEnrollment Dates: February 9 to March 16, 2020
This course may not currently be available to learners in some states and territories.